JP2022534110A - 生物学的乳房インプラント - Google Patents
生物学的乳房インプラント Download PDFInfo
- Publication number
- JP2022534110A JP2022534110A JP2021570399A JP2021570399A JP2022534110A JP 2022534110 A JP2022534110 A JP 2022534110A JP 2021570399 A JP2021570399 A JP 2021570399A JP 2021570399 A JP2021570399 A JP 2021570399A JP 2022534110 A JP2022534110 A JP 2022534110A
- Authority
- JP
- Japan
- Prior art keywords
- tissue
- tissue product
- linking
- implant
- suspension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/12—Mammary prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
- A61F2240/002—Designing or making customized prostheses
- A61F2240/004—Using a positive or negative model, e.g. moulds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/04—Materials or treatment for tissue regeneration for mammary reconstruction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Dispersion Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025141842A JP2026012665A (ja) | 2019-05-30 | 2025-08-28 | 生物学的乳房インプラント |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962854678P | 2019-05-30 | 2019-05-30 | |
| US62/854,678 | 2019-05-30 | ||
| PCT/US2020/035223 WO2020243497A1 (en) | 2019-05-30 | 2020-05-29 | Biologic breast implant |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025141842A Division JP2026012665A (ja) | 2019-05-30 | 2025-08-28 | 生物学的乳房インプラント |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022534110A true JP2022534110A (ja) | 2022-07-27 |
| JP2022534110A5 JP2022534110A5 (cg-RX-API-DMAC7.html) | 2023-05-18 |
Family
ID=71787079
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021570399A Pending JP2022534110A (ja) | 2019-05-30 | 2020-05-29 | 生物学的乳房インプラント |
| JP2025141842A Pending JP2026012665A (ja) | 2019-05-30 | 2025-08-28 | 生物学的乳房インプラント |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025141842A Pending JP2026012665A (ja) | 2019-05-30 | 2025-08-28 | 生物学的乳房インプラント |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11633521B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3976127B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2022534110A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2020283895B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021024043A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3142151A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3056561T3 (cg-RX-API-DMAC7.html) |
| MX (2) | MX2021014654A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020243497A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11246994B2 (en) | 2017-10-19 | 2022-02-15 | Lifecell Corporation | Methods for introduction of flowable acellular tissue matrix products into a hand |
| JP7463273B2 (ja) | 2017-10-19 | 2024-04-08 | ライフセル コーポレーション | 流動性無細胞組織マトリックス製品および製造方法 |
| AU2020267589B2 (en) | 2019-05-08 | 2024-01-04 | Musculoskeletal Transplant Foundation | Tissue derived porous matrices and methods for making and using same |
| EP3976127B1 (en) * | 2019-05-30 | 2025-09-24 | LifeCell Corporation | Biologic breast implant |
| US20210308336A1 (en) * | 2020-04-03 | 2021-10-07 | Lifecell Corporation | Adipose tissue matrix with tropoelastin |
| FR3165647A1 (fr) | 2024-08-26 | 2026-02-27 | Hugo Alberto Drago | Prothèse universelle biologique de matrice dermique acellulaire (ADM) destinée à être utilisée dans des processus de reconstruction corporelle et méthode de fabrication |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120310367A1 (en) * | 2011-05-31 | 2012-12-06 | Lifecell Corporation | Adipose tissue matrices |
| WO2017139100A1 (en) * | 2016-02-08 | 2017-08-17 | Lifecell Corporation | Biologic breast implant |
| WO2019079570A1 (en) * | 2017-10-18 | 2019-04-25 | Lifecell Corporation | ADIPOSE TISSUE PRODUCTS AND METHODS OF PRODUCTION |
Family Cites Families (156)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1562244A (en) | 1976-11-11 | 1980-03-05 | Lock P M | Wound dressing materials |
| US4569348A (en) | 1980-02-22 | 1986-02-11 | Velcro Usa Inc. | Catheter tube holder strap |
| US4373519A (en) | 1981-06-26 | 1983-02-15 | Minnesota Mining And Manufacturing Company | Composite wound dressing |
| US4582640A (en) | 1982-03-08 | 1986-04-15 | Collagen Corporation | Injectable cross-linked collagen implant material |
| IL74715A0 (en) | 1984-03-27 | 1985-06-30 | Univ New Jersey Med | Biodegradable matrix and methods for producing same |
| US4969912A (en) | 1988-02-18 | 1990-11-13 | Kelman Charles D | Human collagen processing and autoimplant use |
| US4950483A (en) | 1988-06-30 | 1990-08-21 | Collagen Corporation | Collagen wound healing matrices and process for their production |
| US5024841A (en) | 1988-06-30 | 1991-06-18 | Collagen Corporation | Collagen wound healing matrices and process for their production |
| US4902508A (en) | 1988-07-11 | 1990-02-20 | Purdue Research Foundation | Tissue graft composition |
| US4938763B1 (en) | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| WO1991006568A1 (en) | 1988-11-07 | 1991-05-16 | Synergen, Inc. | High molecular weight human angiogenic factors |
| US5104409A (en) | 1989-01-10 | 1992-04-14 | Baker James L | Mammary implant |
| JP2719671B2 (ja) | 1989-07-11 | 1998-02-25 | 日本ゼオン株式会社 | 創傷被覆材 |
| US5290558A (en) | 1989-09-21 | 1994-03-01 | Osteotech, Inc. | Flowable demineralized bone powder composition and its use in bone repair |
| US5131850A (en) | 1989-11-03 | 1992-07-21 | Cryolife, Inc. | Method for cryopreserving musculoskeletal tissues |
| US5104957A (en) | 1990-02-28 | 1992-04-14 | Autogenesis Technologies, Inc. | Biologically compatible collagenous reaction product and articles useful as medical implants produced therefrom |
| US5336616A (en) | 1990-09-12 | 1994-08-09 | Lifecell Corporation | Method for processing and preserving collagen-based tissues for transplantation |
| AU650045B2 (en) | 1990-09-12 | 1994-06-09 | Lifecell Corporation | Method and apparatus for cryopreparation dry stabilization and rehydration of biological suspensions |
| US8067149B2 (en) | 1990-09-12 | 2011-11-29 | Lifecell Corporation | Acellular dermal matrix and method of use thereof for grafting |
| US5231169A (en) | 1990-10-17 | 1993-07-27 | Norian Corporation | Mineralized collagen |
| US5263971A (en) | 1991-02-13 | 1993-11-23 | Life Medical Sciences, Inc. | Apparatus for the closure of wide skin defects by stretching of skin |
| US5254133A (en) | 1991-04-24 | 1993-10-19 | Seid Arnold S | Surgical implantation device and related method of use |
| US5149331A (en) | 1991-05-03 | 1992-09-22 | Ariel Ferdman | Method and device for wound closure |
| US5160313A (en) | 1991-05-14 | 1992-11-03 | Cryolife, Inc. | Process for preparing tissue for transplantation |
| US5636643A (en) | 1991-11-14 | 1997-06-10 | Wake Forest University | Wound treatment employing reduced pressure |
| US7198046B1 (en) | 1991-11-14 | 2007-04-03 | Wake Forest University Health Sciences | Wound treatment employing reduced pressure |
| US5645081A (en) | 1991-11-14 | 1997-07-08 | Wake Forest University | Method of treating tissue damage and apparatus for same |
| US5641518A (en) | 1992-11-13 | 1997-06-24 | Purdue Research Foundation | Method of repairing bone tissue |
| US5275826A (en) | 1992-11-13 | 1994-01-04 | Purdue Research Foundation | Fluidized intestinal submucosa and its use as an injectable tissue graft |
| US5437651A (en) | 1993-09-01 | 1995-08-01 | Research Medical, Inc. | Medical suction apparatus |
| US5549584A (en) | 1994-02-14 | 1996-08-27 | The Kendall Company | Apparatus for removing fluid from a wound |
| ATE265191T1 (de) | 1994-03-14 | 2004-05-15 | Cryolife Inc | Herstellungsverfahren von gewebe zur implantation |
| US5489304A (en) | 1994-04-19 | 1996-02-06 | Brigham & Women's Hospital | Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft |
| US5906827A (en) | 1994-06-03 | 1999-05-25 | Creative Biomolecules, Inc. | Matrix for the manufacture of autogenous replacement body parts |
| US5599852A (en) | 1994-10-18 | 1997-02-04 | Ethicon, Inc. | Injectable microdispersions for soft tissue repair and augmentation |
| US5622867A (en) | 1994-10-19 | 1997-04-22 | Lifecell Corporation | Prolonged preservation of blood platelets |
| US6485723B1 (en) | 1995-02-10 | 2002-11-26 | Purdue Research Foundation | Enhanced submucosal tissue graft constructs |
| US5834232A (en) | 1996-05-01 | 1998-11-10 | Zymogenetics, Inc. | Cross-linked gelatin gels and methods of making them |
| US6666892B2 (en) | 1996-08-23 | 2003-12-23 | Cook Biotech Incorporated | Multi-formed collagenous biomaterial medical device |
| US6066325A (en) | 1996-08-27 | 2000-05-23 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
| US6998418B1 (en) | 1996-11-05 | 2006-02-14 | Gp Medical, Inc. | Acellular biological material chemically treated with genipin |
| WO1998019719A1 (en) | 1996-11-05 | 1998-05-14 | Purdue Research Foundation | Myocardial graft constructs |
| AUPO599897A0 (en) | 1997-04-03 | 1997-05-01 | Vidal, Linus | Clear collagen for facial implants |
| US5993844A (en) | 1997-05-08 | 1999-11-30 | Organogenesis, Inc. | Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix |
| US6135116A (en) | 1997-07-28 | 2000-10-24 | Kci Licensing, Inc. | Therapeutic method for treating ulcers |
| US6613278B1 (en) | 1998-11-13 | 2003-09-02 | Regeneration Technologies, Inc. | Tissue pooling process |
| GB9719520D0 (en) | 1997-09-12 | 1997-11-19 | Kci Medical Ltd | Surgical drape and suction heads for wound treatment |
| US8668737B2 (en) | 1997-10-10 | 2014-03-11 | Senorx, Inc. | Tissue marking implant |
| US6371992B1 (en) | 1997-12-19 | 2002-04-16 | The Regents Of The University Of California | Acellular matrix grafts: preparation and use |
| US6071267A (en) | 1998-02-06 | 2000-06-06 | Kinetic Concepts, Inc. | Medical patient fluid management interface system and method |
| US6326018B1 (en) | 1998-02-27 | 2001-12-04 | Musculoskeletal Transplant Foundation | Flexible sheet of demineralized bone |
| US20030039678A1 (en) | 1998-03-16 | 2003-02-27 | Stone Kevin R. | Xenograft bone matrix for orthopedic applications |
| US6179872B1 (en) | 1998-03-17 | 2001-01-30 | Tissue Engineering | Biopolymer matt for use in tissue repair and reconstruction |
| US6432710B1 (en) | 1998-05-22 | 2002-08-13 | Isolagen Technologies, Inc. | Compositions for regenerating tissue that has deteriorated, and methods for using such compositions |
| CA2332986C (en) | 1998-05-26 | 2009-09-08 | Lifecell Corporation | Cryopreservation of human red blood cells |
| AU746973B2 (en) | 1998-06-19 | 2002-05-09 | Lifecell Corporation | Particulate acellular tissue matrix |
| US6933326B1 (en) | 1998-06-19 | 2005-08-23 | Lifecell Coporation | Particulate acellular tissue matrix |
| WO2000016822A1 (en) | 1998-09-21 | 2000-03-30 | The Brigham And Women's Hospital, Inc. | Compositions and methods for tissue repair |
| US6565874B1 (en) | 1998-10-28 | 2003-05-20 | Atrix Laboratories | Polymeric delivery formulations of leuprolide with improved efficacy |
| WO2000047114A1 (en) | 1999-02-12 | 2000-08-17 | Collagenesis, Inc. | Injectable collagen-based delivery system for bone morphogenic proteins |
| US6856821B2 (en) | 2000-05-26 | 2005-02-15 | Kci Licensing, Inc. | System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure |
| US6599318B1 (en) | 1999-11-30 | 2003-07-29 | Shlomo Gabbay | Implantable support apparatus and method of using same |
| US6576265B1 (en) | 1999-12-22 | 2003-06-10 | Acell, Inc. | Tissue regenerative composition, method of making, and method of use thereof |
| EP1320390A2 (en) | 2000-09-18 | 2003-06-25 | Organogenesis Inc. | Bioengineered flat sheet graft prosthesis and its use |
| IL139708A0 (en) | 2000-11-15 | 2002-02-10 | Amiel Gilad | Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering |
| CA2365376C (en) | 2000-12-21 | 2006-03-28 | Ethicon, Inc. | Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration |
| US7070584B2 (en) | 2001-02-20 | 2006-07-04 | Kci Licensing, Inc. | Biocompatible wound dressing |
| US7700819B2 (en) | 2001-02-16 | 2010-04-20 | Kci Licensing, Inc. | Biocompatible wound dressing |
| US7763769B2 (en) | 2001-02-16 | 2010-07-27 | Kci Licensing, Inc. | Biocompatible wound dressing |
| US7153518B2 (en) | 2001-08-27 | 2006-12-26 | Regeneration Technologies, Inc. | Processed soft tissue for topical or internal application |
| US20030143207A1 (en) | 2001-10-18 | 2003-07-31 | Livesey Stephen A. | Remodeling of tissues and organ |
| JP4489437B2 (ja) | 2002-02-21 | 2010-06-23 | エンセル,インコーポレイテッド | 表面コーティングとしての固定化生物活性ヒドロゲルマトリックス |
| AU2003225516A1 (en) | 2002-03-26 | 2003-10-08 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Responsive biomedical composites |
| US20030225347A1 (en) | 2002-06-03 | 2003-12-04 | Argenta Louis C. | Directed tissue growth employing reduced pressure |
| US7498040B2 (en) | 2005-10-12 | 2009-03-03 | Lifenet Health | Compositions for repair of defects in osseous tissues, and methods of making the same |
| US20040037735A1 (en) | 2002-08-23 | 2004-02-26 | Depaula Carl Alexander | Allograft tissue purification process for cleaning bone |
| US6840960B2 (en) | 2002-09-27 | 2005-01-11 | Stephen K. Bubb | Porous implant system and treatment method |
| US7402319B2 (en) | 2002-09-27 | 2008-07-22 | Board Of Regents, The University Of Texas System | Cell-free tissue replacement for tissue engineering |
| US7824701B2 (en) | 2002-10-18 | 2010-11-02 | Ethicon, Inc. | Biocompatible scaffold for ligament or tendon repair |
| US7115100B2 (en) | 2002-11-15 | 2006-10-03 | Ethicon, Inc. | Tissue biopsy and processing device |
| US20040162613A1 (en) * | 2003-02-06 | 2004-08-19 | Thomas Roballey | Cosmetic and reconstructive prosthesis containing a biologically compatible rupture indicator |
| FR2856305B1 (fr) | 2003-06-19 | 2007-08-24 | Inst Nat Sante Rech Med | Protheses avec revetements biologiquement actifs |
| ES2569780T3 (es) | 2003-06-27 | 2016-05-12 | DePuy Synthes Products, Inc. | Células posparto derivadas de tejido placentario y métodos de preparación y uso de las mismas |
| AU2004259019B2 (en) | 2003-07-21 | 2010-09-23 | Lifecell Corporation | Acellular tissue matrices made from galactose alpha-1,3-galactose-deficient tissue |
| US6802861B1 (en) | 2003-08-26 | 2004-10-12 | Rsh-Gs Trust | Structured breast implant |
| US7901461B2 (en) | 2003-12-05 | 2011-03-08 | Ethicon, Inc. | Viable tissue repair implants and methods of use |
| JP2007529278A (ja) | 2004-03-17 | 2007-10-25 | レビビコア, インコーポレイテッド | 機能的α1,3ガラクトシルトランスフェラーゼを欠く動物に由来する組織生成物 |
| US20070190108A1 (en) * | 2004-05-17 | 2007-08-16 | Arindam Datta | High performance reticulated elastomeric matrix preparation, properties, reinforcement, and use in surgical devices, tissue augmentation and/or tissue repair |
| KR100680134B1 (ko) | 2004-06-10 | 2007-02-08 | 박우삼 | 무세포 진피를 주사가능하도록 입자 형태로 가공한 필러 |
| US20060058892A1 (en) | 2004-09-16 | 2006-03-16 | Lesh Michael D | Valved tissue augmentation implant |
| US20060073592A1 (en) | 2004-10-06 | 2006-04-06 | Wendell Sun | Methods of storing tissue matrices |
| US7905826B2 (en) | 2004-11-03 | 2011-03-15 | Cook Incorporated | Methods for modifying vascular vessel walls |
| DE102005002644A1 (de) | 2005-01-19 | 2006-07-20 | Schülke & Mayr GmbH | Zusammensetzungen für die hygienische Händedesinfektion und die desinfizierende Händewaschung |
| WO2006116210A2 (en) | 2005-04-25 | 2006-11-02 | Bernstein Eric F | Dermal fillers for biomedical applications in mammals and methods of using the same |
| ES2668551T3 (es) | 2005-09-26 | 2018-05-18 | Lifecell Corporation | Composición seca de plaquetas |
| US7498041B2 (en) | 2005-10-12 | 2009-03-03 | Lifenet Health | Composition for repair of defects in osseous tissues |
| JP5002805B2 (ja) | 2005-10-14 | 2012-08-15 | 財団法人ヒューマンサイエンス振興財団 | 生物由来スキャフォールドの作製方法 |
| US9456860B2 (en) | 2006-03-14 | 2016-10-04 | Kci Licensing, Inc. | Bioresorbable foaming tissue dressing |
| US8029498B2 (en) | 2006-03-14 | 2011-10-04 | Kci Licensing Inc. | System for percutaneously administering reduced pressure treatment using balloon dissection |
| US20070248575A1 (en) | 2006-04-19 | 2007-10-25 | Jerome Connor | Bone graft composition |
| EP2021536B1 (en) | 2006-04-24 | 2014-02-26 | Coloplast A/S | Non-woven structures produced by a non-toxic dry solvent spinning process |
| EP2015707B1 (en) | 2006-05-09 | 2019-01-23 | LifeCell Corporation | Reinforced biological tissue |
| JP5050197B2 (ja) | 2006-07-31 | 2012-10-17 | 財団法人ヒューマンサイエンス振興財団 | 生物由来スキャフォールドの作製方法 |
| US20080114277A1 (en) | 2006-11-09 | 2008-05-15 | Archel Ambrosio | Porous bioresorbable dressing conformable to a wound and methods of making same |
| WO2008134305A2 (en) | 2007-04-26 | 2008-11-06 | Johnson & Johnson Regenerative Therapeutics, Llc | Tissue engineering devices and methods for luminal organs |
| US20080281418A1 (en) | 2007-05-09 | 2008-11-13 | Leigh Hunt Firestone | Breast implant articles of multi-layered sheets of extracellular matrix or balled strips and pieces of extracellular matrix |
| US9034367B2 (en) | 2007-05-10 | 2015-05-19 | Cormatrix Cardiovascular, Inc. | Articles for tissue regeneration with biodegradable polymer |
| US20080281419A1 (en) | 2007-05-10 | 2008-11-13 | Matheny Robert G | Breast implants and compositions of extracellular matrix |
| WO2009006226A1 (en) | 2007-06-29 | 2009-01-08 | Kci Licensing Inc. | Activation of bone and cartilage formation |
| DK3473260T3 (da) | 2007-07-10 | 2020-12-21 | Lifecell Corp | Acellulære vævsmatrixs-sammensætninger til vævsreparation |
| US20090024224A1 (en) | 2007-07-16 | 2009-01-22 | Chen Silvia S | Implantation of cartilage |
| US9782300B2 (en) | 2008-02-01 | 2017-10-10 | Kci Licensing, Inc. | Fiber-microsphere bioresorbable composite scaffold for wound healing |
| AU2009246365B2 (en) | 2008-05-13 | 2015-04-16 | Kci Licensing, Inc. | Catheter/filament style device and methods for treatment of wounds beneath the surface of the skin |
| AU2009256193B2 (en) | 2008-06-06 | 2015-04-23 | Lifecell Corporation | Elastase treatment of tissue matrices |
| CA2840415C (en) | 2008-06-25 | 2018-01-02 | Kci Licensing, Inc. | Absorbable, reduced-pressure manifolds and systems |
| EP2288396B1 (en) | 2008-06-26 | 2016-06-15 | KCI Licensing, Inc. | Stimulation of cartilage formation using reduced pressure treatment and chondrocytes |
| US9050184B2 (en) | 2008-08-13 | 2015-06-09 | Allergan, Inc. | Dual plane breast implant |
| EP2319548B1 (en) | 2008-08-14 | 2016-06-01 | KCI Licensing, Inc. | Tissue scaffolds |
| US7927414B2 (en) | 2008-09-05 | 2011-04-19 | Ethicon, Inc. | Method of manufacturing acellular matrix glue |
| AU2009316588B2 (en) | 2008-11-21 | 2014-09-11 | Stout Medical Group, L.P. | Reinforced biologic material |
| CA2745903C (en) | 2008-12-31 | 2018-07-17 | Kci Licensing, Inc. | System for providing fluid flow to nerve tissues |
| JP5628203B2 (ja) | 2008-12-31 | 2014-11-19 | ケーシーアイ ライセンシング インコーポレイテッド | 組織の成長を刺激する流体フローを誘発するシステム |
| KR20110117129A (ko) | 2008-12-31 | 2011-10-26 | 케이씨아이 라이센싱 인코포레이티드 | 조직에 유체 흐름을 제공하기 위한 시스템 |
| CA2762212C (en) | 2009-05-20 | 2015-12-29 | Humacyte, Inc. | Elastin for soft tissue augmentation |
| US8986377B2 (en) | 2009-07-21 | 2015-03-24 | Lifecell Corporation | Graft materials for surgical breast procedures |
| CA2770490C (en) | 2009-08-11 | 2024-04-16 | The Johns Hopkins University | Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products |
| US20110093069A1 (en) | 2009-10-16 | 2011-04-21 | Allergan, Inc. | Implants and methdos for manufacturing same |
| CN102711859B (zh) | 2010-01-22 | 2016-02-24 | 凯希特许有限公司 | 用负压伤口疗法滴注发泡流体的器件、系统及方法 |
| US8632512B2 (en) | 2010-04-09 | 2014-01-21 | Kci Licensing, Inc. | Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds |
| AU2011276246B2 (en) | 2010-07-08 | 2014-12-04 | Lifecell Corporation | Method for shaping tissue matrices |
| US20120040013A1 (en) | 2010-08-10 | 2012-02-16 | LifeCell Corporation. | Regenerative Tissue Scaffolds |
| US20120232652A1 (en) | 2011-03-07 | 2012-09-13 | Rolando Mora | Implant with a visual indicator of a barrier layer |
| BR112013026200A2 (pt) | 2011-04-14 | 2019-08-27 | Lifecell Corp | método para preparar uma composição de matriz de tecido, e matriz de tecido |
| EP3243533B1 (en) | 2011-10-11 | 2020-06-17 | Allergan Holdings France S.A.S. | Threads of cross-linked hyaluronic acid and methods of use thereof |
| EP3622974A1 (en) | 2011-11-10 | 2020-03-18 | LifeCell Corporation | Method for elimination of space through tissue approximation |
| US9532863B2 (en) | 2011-12-20 | 2017-01-03 | Lifecell Corporation | Sheet tissue products |
| CA2859657C (en) | 2011-12-20 | 2021-03-02 | Lifecell Corporation | Acellular tissue matrix particles and flowable products comprising them |
| BR112014026090A8 (pt) | 2012-04-24 | 2019-08-27 | Lifecell Corp | composição de matriz tecidual apta a fluir |
| CA2871635A1 (en) | 2012-04-24 | 2013-10-31 | Lifecell Corporation | Functionalized tissue matrices comprising chelated metals |
| CN105142572B (zh) | 2013-01-30 | 2018-05-11 | 因普利特有限公司 | 人类可植入的组织扩张器 |
| WO2015017500A1 (en) | 2013-07-30 | 2015-02-05 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
| US10722614B2 (en) | 2013-09-25 | 2020-07-28 | The University Of Kansas | Decellularized hyaline cartilage powder for tissue scaffolds |
| US10092392B2 (en) | 2014-05-16 | 2018-10-09 | Allergan, Inc. | Textured breast implant and methods of making same |
| WO2016022670A1 (en) * | 2014-08-05 | 2016-02-11 | The University Of Memphis | Compositions and methods for enhancing healing and regeneration of bone and soft tissue |
| KR20170070008A (ko) * | 2014-08-15 | 2017-06-21 | 더 존스 홉킨스 유니버시티 | 조직 복원용 복합 재료 |
| EP3337423B1 (en) * | 2015-08-17 | 2023-06-07 | The Johns Hopkins University | Fiber-hydrogel composite surgical meshes for tissue repair |
| GB201514788D0 (en) | 2015-08-20 | 2015-10-07 | Ecole Polytech | Malleable scaffold material and uses thereof |
| CN108697828A (zh) * | 2016-02-11 | 2018-10-23 | 生命细胞公司 | 用于稳定包含胶原蛋白的组织产品防止酶降解的方法 |
| ES2841427T3 (es) * | 2016-07-05 | 2021-07-08 | Lifecell Corp | Matrices de tejido que incorporan múltiples tipos de tejido |
| US11123375B2 (en) * | 2017-10-18 | 2021-09-21 | Lifecell Corporation | Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products |
| JP7463273B2 (ja) | 2017-10-19 | 2024-04-08 | ライフセル コーポレーション | 流動性無細胞組織マトリックス製品および製造方法 |
| US11246994B2 (en) | 2017-10-19 | 2022-02-15 | Lifecell Corporation | Methods for introduction of flowable acellular tissue matrix products into a hand |
| US12151050B2 (en) * | 2018-03-01 | 2024-11-26 | Tepha, Inc. | Medical devices containing compositions of poly(butylene succinate) and copolymers thereof |
| EP3790602A1 (en) * | 2018-05-09 | 2021-03-17 | The Johns Hopkins University | Nanofiber-hydrogel composites for cell and tissue delivery |
| BR112021006348A2 (pt) * | 2018-10-03 | 2021-07-06 | Estab Labs Sa | andaime para dispositivos médicos implantáveis e mé-todos de uso dos mesmos |
| EP3976127B1 (en) * | 2019-05-30 | 2025-09-24 | LifeCell Corporation | Biologic breast implant |
-
2020
- 2020-05-29 EP EP20746380.3A patent/EP3976127B1/en active Active
- 2020-05-29 JP JP2021570399A patent/JP2022534110A/ja active Pending
- 2020-05-29 US US16/887,629 patent/US11633521B2/en active Active
- 2020-05-29 EP EP25196991.1A patent/EP4670751A3/en active Pending
- 2020-05-29 AU AU2020283895A patent/AU2020283895B2/en active Active
- 2020-05-29 WO PCT/US2020/035223 patent/WO2020243497A1/en not_active Ceased
- 2020-05-29 BR BR112021024043A patent/BR112021024043A2/pt unknown
- 2020-05-29 MX MX2021014654A patent/MX2021014654A/es unknown
- 2020-05-29 ES ES20746380T patent/ES3056561T3/es active Active
- 2020-05-29 CA CA3142151A patent/CA3142151A1/en active Pending
-
2021
- 2021-11-29 MX MX2026004761A patent/MX2026004761A/es unknown
-
2023
- 2023-03-09 US US18/119,753 patent/US20230211048A1/en active Pending
-
2025
- 2025-08-28 JP JP2025141842A patent/JP2026012665A/ja active Pending
-
2026
- 2026-06-11 AU AU2026204492A patent/AU2026204492A1/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120310367A1 (en) * | 2011-05-31 | 2012-12-06 | Lifecell Corporation | Adipose tissue matrices |
| WO2017139100A1 (en) * | 2016-02-08 | 2017-08-17 | Lifecell Corporation | Biologic breast implant |
| WO2019079570A1 (en) * | 2017-10-18 | 2019-04-25 | Lifecell Corporation | ADIPOSE TISSUE PRODUCTS AND METHODS OF PRODUCTION |
Non-Patent Citations (1)
| Title |
|---|
| INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, vol. 55, JPN6024006224, 2013, pages 221 - 230, ISSN: 0005432340 * |
Also Published As
| Publication number | Publication date |
|---|---|
| MX2026004761A (es) | 2026-06-01 |
| MX2021014654A (es) | 2022-03-11 |
| CA3142151A1 (en) | 2020-12-03 |
| AU2020283895B2 (en) | 2026-07-02 |
| EP3976127B1 (en) | 2025-09-24 |
| AU2026204492A1 (en) | 2026-07-02 |
| JP2026012665A (ja) | 2026-01-27 |
| EP3976127A1 (en) | 2022-04-06 |
| ES3056561T3 (en) | 2026-02-23 |
| EP4670751A2 (en) | 2025-12-31 |
| US11633521B2 (en) | 2023-04-25 |
| BR112021024043A2 (pt) | 2022-02-08 |
| US20200376160A1 (en) | 2020-12-03 |
| EP4670751A3 (en) | 2026-03-18 |
| US20230211048A1 (en) | 2023-07-06 |
| AU2020283895A1 (en) | 2022-01-06 |
| WO2020243497A1 (en) | 2020-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7559144B2 (ja) | 脂肪組織製品および製造方法 | |
| EP3413938B1 (en) | Biologic breast implant | |
| US20230211048A1 (en) | Biologic breast implant | |
| EP2900288B1 (en) | Processed adipose tissue | |
| AU2021200593A1 (en) | Adipose tissue matrices | |
| US11123375B2 (en) | Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products | |
| JP7307527B2 (ja) | 制御された多孔性または機械的特性を有する組織マトリックス | |
| US20210052774A1 (en) | Fixed-shape tissue matrix and related methods | |
| US20240416010A1 (en) | Adipose tissue matrix with tropoelastin | |
| HK1246212B (en) | Tissue matrices with controlled porosity or mechanical properties |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230510 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230510 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240220 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20240221 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240515 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240722 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240819 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20241008 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20241220 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20250430 |